"Uusi lastensairaala on lasten vaativaan erikoissairaanhoitoon keskittynyt sairaala. Sairaalassa hoidetaan potilaita kaikkialta Suomesta. Uudessa lastensairaalassa hoidetaan potilaita vastasyntyneistä 15-vuotiaisiin. Uudessa lastensairaalassa perhe saa olla yhdessä. Vanhemmat voivat olla lapsensa luona ympäri vuorokauden. Sairaalapäivystys on avoinna ympäri vuorokauden. Pääsääntöisesti hoitoon tullaan lähetteellä. Äkillisesti sairastuneen lapsen ja nuoren ensisijainen hoitopaikka on arkisin klo 8–16 oma terveysasema ja klo 16 jälkeen Uuden lastensairaalan yhteispäivystys. Kahvio sijaitsee sairaalan 2. kerroksessa. Kahvion aukioloajat ma–pe klo 8.00–16.00 la–su klo 10.00–15.00"

During the past decade, Helsinki University Hospital, Dept of Paediatrics conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helsinki University Hospital, Dept of Paediatrics" #1 collaborator was "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator, "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Helsinki University Hospital, Dept of Paediatrics" are "Leukemia, Acute Lymphoblastic" (2 trials). Many other conditions were trialed in "Helsinki University Hospital, Dept of Paediatrics" in a lesser frequency.

Most popular intervention types in "Helsinki University Hospital, Dept of Paediatrics" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Blinatumomab" (1 trials), "Imatinib" (1 trials), "Inotuzumab Ozogamicin+Standard Maintenance Therapy" (1 trials) and "Observational" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helsinki University Hospital, Dept of Paediatrics" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Helsinki University Hospital, Dept of Paediatrics". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Helsinki University Hospital, Dept of Paediatrics, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Helsinki University Hospital, Dept of Paediatrics, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".